Abeona Therapeutics Company Profile (NASDAQ:ABEO)

About Abeona Therapeutics

Abeona Therapeutics logoAbeona Therapeutics, Inc. (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is focused on developing and delivering gene therapy and plasma-based products for rare diseases. The Company's lead programs are ABO-101 (AA9 NAGLU) and ABO-102 (scAAV9 SGHG), adeno-associated virus (AAV)-based gene therapies for Sanfilippo syndrome (Mucopolysaccharidosis (MPS) IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. The Company is also developing ABO-201 (scAAV9 CLN3) gene therapy for juvenile Batten disease (JBD), and ABO-301 (AAV LK19 FANCC) for Fanconi anemia (FA) disorder using a clustered, regularly interspaced short palindromic repeats (CRISPR)/Cas9-based gene editing approach to gene therapy program for rare blood diseases. It is developing rare plasma protein therapies, including PTB-101 SDF Alpha (alpha-1 protease inhibitor) for inherited chronic obstructive pulmonary disease. Its product pipeline also consists of MuGard and ProdiGard.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ABEO
  • CUSIP:
Key Metrics:
  • Previous Close: $5.91
  • 50 Day Moving Average: $4.80
  • 200 Day Moving Average: $3.25
  • 52-Week Range: $2.05 - $6.80
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -11.76
  • P/E Growth: 0.00
  • Market Cap: $198.25M
  • Outstanding Shares: 33,545,000
  • Beta: 1.33
Profitability:
  • Net Margins: -2,177.03%
  • Return on Equity: -30.84%
  • Return on Assets: -25.73%
Debt:
  • Current Ratio: 3.98%
  • Quick Ratio: 3.98%
Additional Links:
Companies Related to Abeona Therapeutics:

Analyst Ratings

Consensus Ratings for Abeona Therapeutics (NASDAQ:ABEO) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $16.75 (179.17% upside)

Analysts' Ratings History for Abeona Therapeutics (NASDAQ:ABEO)
Show:
DateFirmActionRatingPrice TargetDetails
9/30/2016Cantor FitzgeraldReiterated RatingBuy$21.00View Rating Details
9/29/2016Maxim GroupReiterated RatingBuy$8.00 -> $14.00View Rating Details
9/21/2016FBR & CoSet Price TargetBuy$15.00View Rating Details
8/21/2016Rodman & RenshawReiterated RatingBuy$17.00View Rating Details
7/20/2015MLV & Co.Initiated CoverageBuy$15.00View Rating Details
6/11/2015Roth CapitalInitiated CoverageBuy$16.00View Rating Details
5/18/2015HC WainwrightInitiated CoverageBuy$15.00View Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Abeona Therapeutics (NASDAQ:ABEO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/15/2016        
8/16/2016Q2($0.14)($0.20)ViewN/AView Earnings Details
5/16/2016Q1($0.13)($0.17)ViewN/AView Earnings Details
3/8/2016Q415($0.07)ViewN/AView Earnings Details
8/20/2015Q215($0.10)($0.16)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Abeona Therapeutics (NASDAQ:ABEO)
Current Year EPS Consensus Estimate: $-0.72 EPS
Next Year EPS Consensus Estimate: $-0.51 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20161($0.17)($0.17)($0.17)
Q4 20161($0.17)($0.17)($0.17)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Abeona Therapeutics (NASDAQ:ABEO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Abeona Therapeutics (NASDAQ:ABEO)
Insider Ownership Percentage: 13.00%
Institutional Ownership Percentage: 19.95%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/20/2016Todd WiderDirectorBuy5,000$5.48$27,400.00View SEC Filing  
7/31/2015Mark J AhnDirectorBuy18,182$5.50$100,001.00View SEC Filing  
1/26/2015Mark J AhnDirectorBuy25,000$4.00$100,000.00View SEC Filing  
12/24/2014Steven H RouhandehDirectorBuy250,000$4.00$1,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Abeona Therapeutics (NASDAQ:ABEO)
DateHeadline
News IconFabry Disease Market Pipeline Review in H2 2016 Report (NASDAQ:ABEO)
www.prnewswire.co.in - September 29 at 8:01 AM
4-traders.com logoAbeona Therapeutics : to Present at Cell Gene Meeting on the Mesa (NASDAQ:ABEO)
www.4-traders.com - September 29 at 8:01 AM
finance.yahoo.com logoAbeona Therapeutics to Present at Cell Gene Meeting on the Mesa (NASDAQ:ABEO)
finance.yahoo.com - September 29 at 8:01 AM
streetinsider.com logoForm 4 ABEONA THERAPEUTICS INC. For: Sep 20 Filed by: Wider Todd - StreetInsider.com (NASDAQ:ABEO)
www.streetinsider.com - September 28 at 3:14 PM
News IconNew Analyst Ratings On Abeona Therapeutics Inc. (ABEO) - NewsDen (NASDAQ:ABEO)
newsden.net - September 28 at 8:02 AM
News IconGlobal batten disease pipeline 2016 market outlook insights shared in detailed report (NASDAQ:ABEO)
www.whatech.com - September 27 at 3:16 PM
marketwired.com logoAbeona Therapeutics Enrolls First Patient in Phase 2 for EB-101 Gene Therapy Clinical Trial for Epidermolysis Bullosa - Marketwired (press release) (NASDAQ:ABEO)
www.marketwired.com - September 26 at 8:19 AM
publicnow.com logoAbeona Therapeutics Enrolls First Patient in Phase 2 for EB-101 Gene Therapy Clinical Trial for Epidermolysis Bullosa (NASDAQ:ABEO)
www.publicnow.com - September 26 at 8:19 AM
News IconStock Tracker: Earnings & Estimates for Abeona Therapeutics Inc (NASDAQ:ABEO) - Frisco Fastball (NASDAQ:ABEO)
friscofastball.com - September 25 at 3:22 PM
barrons.com logo[$$] Abeona Expands Opportunity With Partnerships (NASDAQ:ABEO)
www.barrons.com - September 24 at 8:08 AM
marketwired.com logoAbeona Therapeutics to Present at Ladenburg Thalmann 2016 Healthcare Conference - Marketwired (press release) (NASDAQ:ABEO)
www.marketwired.com - September 23 at 8:04 AM
finance.yahoo.com logoAbeona Therapeutics to Present at Ladenburg Thalmann 2016 Healthcare Conference (NASDAQ:ABEO)
finance.yahoo.com - September 23 at 8:04 AM
News IconTime To Put On The Watch List? - Abeona Therapeutics (NASDAQ:ABEO), ImmunoGen (NASDAQ:IMGN) - The Voice Registrar (NASDAQ:ABEO)
voiceregistrar.com - September 22 at 3:16 PM
finance.yahoo.com logo263% Upside Seen In Abeona Therapeutics (NASDAQ:ABEO)
finance.yahoo.com - September 22 at 8:12 AM
News IconAbeona Therapeutics Inc (NASDAQ:ABEO) Skyrocketed 20% In Two week, Power of The Chart - Market News Call (NASDAQ:ABEO)
www.marketnewscall.com - September 21 at 3:22 PM
benzinga.com logo263% Upside Seen In Abeona Therapeutics - Benzinga (NASDAQ:ABEO)
www.benzinga.com - September 21 at 3:22 PM
publicnow.com logoAbeona Therapeutics Announces Licensing of the AIM(TM) Next Generation AAV Gene Therapy Vector Platform From The University of North Carolina at Chapel Hill (NASDAQ:ABEO)
www.publicnow.com - September 21 at 10:59 AM
capitalcube.com logoETF’s with exposure to Abeona Therapeutics, Inc. : September 21, 2016 (NASDAQ:ABEO)
www.capitalcube.com - September 21 at 10:59 AM
News IconStock Perspective: Abeona Therapeutics Inc (NASDAQ:ABEO) Company Earnings Watch - Frisco Fastball (NASDAQ:ABEO)
friscofastball.com - September 20 at 3:16 PM
finance.yahoo.com logoAbeona Therapeutics to Present at 2016 Aegis Growth Conference - Yahoo Finance (NASDAQ:ABEO)
finance.yahoo.com - September 18 at 3:16 PM
marketwired.com logoAbeona Therapeutics to Present at 2016 Aegis Growth Conference - Marketwired (press release) (NASDAQ:ABEO)
www.marketwired.com - September 17 at 3:16 PM
4-traders.com logoAbeona Therapeutics : enrols 5th patient in gene therapy Epidermolysis Bullosa trial (NASDAQ:ABEO)
www.4-traders.com - September 17 at 8:03 AM
News IconEarnings Take Center Stage; Analysts Weighing in on Abeona Therapeutics Inc (NASDAQ:ABEO) - Frisco Fastball (NASDAQ:ABEO)
friscofastball.com - September 12 at 3:16 PM
News IconShares Higher in Today's Session: Abeona Therapeutics Inc. (NASDAQ:ABEO) - Post News (NASDAQ:ABEO)
www.kentuckypostnews.com - September 9 at 3:16 PM
investingnews.com logoAbeona Therapeutics Enrolls 5th Patient in Phase 1/2 Gene Therapy Clinical Trial - Investing News Network (press release) (registration) (blog) (NASDAQ:ABEO)
investingnews.com - September 9 at 3:16 PM
News IconStock Gapping Higher Pre-Market: Abeona Therapeutics Inc. (NASDAQ:ABEO) - Post News (NASDAQ:ABEO)
www.kentuckypostnews.com - September 8 at 3:16 PM
News IconAbeona Therapeutics Inc. (ABEO) Trading Up 1.7% - NewsDen (NASDAQ:ABEO)
newsden.net - September 8 at 3:16 PM
reuters.com logoBRIEF-Abeona Therapeutics says enrolls 5th patient in Phase 1/2 gene therapy clinical trial for Epidermolysis Bullosa (NASDAQ:ABEO)
www.reuters.com - September 8 at 12:14 PM
schaeffersresearch.com logoAnalyst Upgrades: Abeona Therapeutics Inc, Twitter Inc, and Hewlett Packard Enterprise Co (NASDAQ:ABEO)
www.schaeffersresearch.com - September 8 at 12:14 PM
publicnow.com logoAbeona Therapeutics Enrolls 5th Patient in Phase 1/2 Gene Therapy Clinical Trial for Epidermolysis Bullosa (NASDAQ:ABEO)
www.publicnow.com - September 8 at 12:14 PM
streetinsider.com logoAfter-Hours Stock Movers 09/07: (RPRX) (JUNO) (ABEO) Higher; (GEVO) (TSCO) (PIR) Lower (more...) (NASDAQ:ABEO)
www.streetinsider.com - September 7 at 8:23 PM
finance.yahoo.com logoAbeona Therapeutics to Present at Rodman & Renshaw 18th Annual Global Investment Conference (NASDAQ:ABEO)
finance.yahoo.com - September 7 at 12:13 PM
finance.yahoo.com logoAbeona Therapeutics to Present at Landmark Angels 6th Annual Investing for Cures 2016 Conference (NASDAQ:ABEO)
finance.yahoo.com - September 1 at 11:42 AM
News IconGlobal Genes Announces Actors, Pop Stars, and Special Performances For the Fifth Annual Tribute to Champions of Hope (NASDAQ:ABEO)
www.wltz.com - August 31 at 8:00 AM
streetinsider.com logoAbeona Therapeutics (ABEO) Concludes ABO-102 Phase 1/2 Enrollment for MPS IIIA Patients (NASDAQ:ABEO)
www.streetinsider.com - August 29 at 3:26 PM
streetinsider.com logoAbeona Therapeutics (ABEO) Concludes ABO-102 Phase 1/2 Enrollment for MPS IIIA Patients - StreetInsider.com (NASDAQ:ABEO)
www.streetinsider.com - August 29 at 8:02 AM
4-traders.com logoABEONA THERAPEUTICS INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) (NASDAQ:ABEO)
www.4-traders.com - August 27 at 8:02 AM
biz.yahoo.com logoABEONA THERAPEUTICS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exh (NASDAQ:ABEO)
biz.yahoo.com - August 27 at 8:02 AM
finance.yahoo.com logoABEONA THERAPEUTICS INC. Financials (NASDAQ:ABEO)
finance.yahoo.com - August 23 at 3:14 PM
capitalcube.com logoETF’s with exposure to Abeona Therapeutics, Inc. : August 19, 2016 (NASDAQ:ABEO)
www.capitalcube.com - August 19 at 3:16 PM
capitalcube.com logoAbeona Therapeutics, Inc. :ABEO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 18, 2016 (NASDAQ:ABEO)
www.capitalcube.com - August 18 at 11:39 AM
seekingalpha.com logoAbeona Therapeutics' (ABEO) CEO Timothy Miller on Q2 2016 Results - Earnings Call Transcript - Seeking Alpha (NASDAQ:ABEO)
seekingalpha.com - August 17 at 8:46 PM
marketwired.com logoAbeona Therapeutics Announces Second Quarter 2016 Financial Results and Recent Clinical Highlights - Marketwired (press release) (NASDAQ:ABEO)
www.marketwired.com - August 16 at 8:34 PM
biz.yahoo.com logoABEONA THERAPEUTICS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and (NASDAQ:ABEO)
biz.yahoo.com - August 16 at 8:34 PM
4-traders.com logoAbeona Therapeutics : reports 2Q loss (NASDAQ:ABEO)
www.4-traders.com - August 16 at 11:52 AM
sg.finance.yahoo.com logoAbeona Therapeutics reports 2Q loss (NASDAQ:ABEO)
sg.finance.yahoo.com - August 16 at 11:52 AM
publicnow.com logoAbeona Therapeutics Announces Second Quarter 2016 Financial Results and Recent Clinical Highlights (NASDAQ:ABEO)
www.publicnow.com - August 16 at 11:52 AM
biz.yahoo.com logoABEONA THERAPEUTICS INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:ABEO)
biz.yahoo.com - August 15 at 8:48 PM
News IconFormFactor, Palo Alto Networks, Concordia International, Abeona Therapeutics and Proteostasis Therapeutics ... - Yahoo Sports (NASDAQ:ABEO)
sports.yahoo.com - August 12 at 3:15 PM
News IconFormFactor, Palo Alto Networks, Concordia International, Abeona Therapeutics ... (NASDAQ:ABEO)
sports.yahoo.com - August 12 at 11:50 AM

Social

Abeona Therapeutics (NASDAQ:ABEO) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff